Skip to main content
Pharming Group N.V. logo

Pharming Group N.V. — Investor Relations & Filings

Ticker · PHARM ISIN · NL0010391025 LEI · 724500DCJ9MPG74JEH91 AS Manufacturing
Open in API
Filings indexed 799 across all filing types
Latest filing 2022-04-22 Regulatory Filings
Country NL Netherlands
Listing AS PHARM

About Pharming Group N.V.

https://www.pharming.com/

Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings
2022-04-22 English
Pharming announces change in its holding in BioConnection following a substantial investment by new investor
Capital/Financing Update Classification · 95% confidence The document is a press release titled "Pharming announces change in its holding in BioConnection following a substantial investment by new investor." It details a transaction where Pharming's minority stake in BioConnection is reduced due to an investment by Gimv, resulting in cash proceeds for Pharming. This type of announcement, concerning changes in shareholding or investment structure related to an associated company, fits best under Capital/Financing Update (CAP) or potentially Major Shareholding Notification (MRQ) if it were about Pharming's own shares crossing a threshold, but here it is about an investment change. Since it involves receiving cash proceeds from a partial divestment/restructuring of an investment, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it directly relates to a change in capital structure/asset value realization. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is a specific corporate action announcement.
2022-04-22 English
Pharming announces the filing of its 2021 Annual Report, with Form 20-F also filed with the U.S. Securities and Exchange Commission and convenes its 2022 AGM
Report Publication Announcement Classification · 100% confidence The document explicitly announces the filing of the '2021 Annual Report' and the 'Form 20-F' with the SEC for the year ended December 31, 2021. It also announces the convening of the 2022 AGM. Since the document's primary purpose is to inform the public that these major reports (Annual Report/20-F) and the AGM notice are now available, and it provides links to where they can be found, it fits the definition of a Report Publication Announcement (RPA) according to Rule 2 ('MENU VS MEAL' Rule). While it mentions the 10-K equivalent (Form 20-F) and AGM, the text itself is an announcement, not the full report or the AGM materials.
2022-04-07 English
6-K
Regulatory Filings
2022-04-06 English
20-F
Annual Report FY 2021
2022-04-06 English
Annual Report 2021
Annual Report Classification · 100% confidence The document is titled 'Annual Report 2021 - Pharming' and contains extensive sections typical of an annual report, including CEO statement, business overview, financial review, risk management, corporate governance, consolidated financial statements, notes, and an independent auditor's report. It covers the full fiscal year 2021 and includes detailed financial data and management discussion. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. Therefore, this document fits the definition of an Annual Report (10-K). FY 2021
2022-04-06 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.